New Features in KIWI 1.5:
KIWI 1.5 continues to bring user experience to a new level through efficient, decisive model building and co-worker collaboration.
Visualize - Visualize diagnostic plots and parameters for all candidate models in one view
Formats / Labels - Fully customized formatting and labeling within KIWI
Cross Project and Co-Worker Graphical Profiles - Share your share suite of customized diagnostic plots with your co-worker or use them on your next project
The EMA and FDA recommend including a run record in your technical report to describe any major decisions and should include an overview of the steps taken during model development. KIWI 1.3, available in May 2015, will reduce the time taken to perform this task to just minutes.
While we now have access to adequate computing power for most applications, we lack the tools required to properly manage the investigative process. We need the tools to organize the results of the numerous model configurations, sort through the results and compare alternative formations of the model in order to determine reasonable next steps and decide that a particular model or group of models is adequate for the task at hand. And this is where the idea of “workflow” comes to the forefront.
KIWI has been specifically designed to recognize the dynamic nature of the model building effort in an ongoing drug development program. KIWI provides functionality to meet the scientists’ need for extensive documentation of the analysis pathway and collateral results, management’s need for summaries of modeling and simulation highlights, and regulatory agencies need for transparency and reproducibility.